Drug intelligence / Profile preview

Optive Advanced

Development stage
Discontinued
Lead developer
Allergan
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Optive Advanced (often marketed as Refresh Optive Advanced) is a triple-action lubricant eye drop formulation developed by Allergan (now part of AbbVie) for the treatment of dry eye syndrome. It is designed to address all three layers of the tear film: the mucoaqueous layer (via carboxymethylcellulose sodium and glycerin) and the lipid layer (via polysorbate 80). The formulation acts as a lubricant to reduce friction, a humectant to hydrate the ocular surface, and an osmoprotectant to protect corneal epithelial cells from hypertonic stress. It is specifically indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to environmental factors such as wind and sun.

Brand names
Optive AdvancedRefresh Optive Advanced
Other names
Optive Advanced Lubricant Eye Drops
02

Targets

GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on Optive Advanced.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optive Advanced.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call